Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer/Squamous Cell Carcinoma of Skin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05363605
What this trial is testing

[225Ac]-FPI-1966 in Participants With Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorHead and Neck Squamous Cell CarcinomaBladder Carcinoma+11 more
Fusion Pharmaceuticals Inc. 6
Testing effectiveness (Phase 2)Study completedNCT02643303
What this trial is testing

Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers

Who this might be right for
Head and Neck Squamous Cell CarcinomaBreast CancerSarcoma+8 more
Ludwig Institute for Cancer Research 58
Not applicableUnknownNCT04805905
What this trial is testing

A Comparison of Skin Grafts Versus Local Flaps for Facial Skin Cancer From the Patient Perspective: A Feasibility Study

Who this might be right for
Skin Cancer, Basal CellSkin CancerSkin Cancer, Non-Melanoma+2 more
McMaster University 30
Testing effectiveness (Phase 2)Study completedNCT03108131
What this trial is testing

Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors

Who this might be right for
Skin Squamous Cell CarcinomaAppendix AdenocarcinomaRare Lesion+9 more
M.D. Anderson Cancer Center 49
Not applicableStudy completedNCT02310503
What this trial is testing

Spanish Registry of Mohs Surgery

Who this might be right for
Skin NeoplasmsCarcinoma, Basal CellCarcinoma, Squamous Cell+4 more
Fundación Academia Española de Dermatología 6,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT02644369
What this trial is testing

Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors

Who this might be right for
Squamous Cell Cancer of Head and NeckTriple Negative Breast CancerEpithelial Ovarian Cancer+2 more
University Health Network, Toronto 100
Not applicableNot Yet RecruitingNCT07384949
What this trial is testing

Correlation of Dermoscopic Findings With Histopathological Features and Invasion Depth in Cutaneous Squamous Cell Carcinoma

Who this might be right for
Cutaneous Squamous Cell Cancer
Istanbul Training and Research Hospital 238
Early research (Phase 1)Looking for participantsNCT04119024
What this trial is testing

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Who this might be right for
Metastatic Malignant Solid NeoplasmMetastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+14 more
Anusha Kalbasi 18
Testing effectiveness (Phase 2)Study completedNCT02347813
What this trial is testing

Preventing Squamous Cell Skin Cancer

Who this might be right for
Squamous Cell Carcinoma of the Skin
University of Rochester 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT05075980
What this trial is testing

Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study

Who this might be right for
Head and Neck CarcinomaHead and Neck Carcinoma of Unknown PrimaryHypopharyngeal Carcinoma+9 more
Mayo Clinic 174
Early research (Phase 1)Study completedNCT04925713
What this trial is testing

IFx-Hu2.0 for the Treatment of Patients With Skin Cancer

Who this might be right for
Cutaneous Squamous Cell CarcinomaBasal Cell Carcinoma
TuHURA Biosciences, Inc. 5
Not applicableNot Yet RecruitingNCT07809191
What this trial is testing

Hair Regrowth Following Partial Thickness Removal of SSCIS

Who this might be right for
Squamous Cell Carcinoma (Skin)Squamous Cell Carcinoma in SituAlopecia
The Cooper Health System 15
Very early researchActive Not RecruitingNCT05358938
What this trial is testing

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Who this might be right for
Cutaneous MelanomaCutaneous Squamous Cell CarcinomaMerkel Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 22
Early research (Phase 1)Looking for participantsNCT06171750
What this trial is testing

Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorCutaneous TumorSubcutaneous Tumor+6 more
Ankyra Therapeutics, Inc 97
Testing effectiveness (Phase 2)Active Not RecruitingNCT05057013
What this trial is testing

A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours

Who this might be right for
Bladder CancerTriple Negative Breast CancerCastration-resistant Prostate Cancer+11 more
Cancer Research UK 81
Testing effectiveness (Phase 2)Ended earlyNCT02042885
What this trial is testing

A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer

Who this might be right for
Prostate CancerSalivary Gland CancerEndometrial Cancer+3 more
Otsuka Novel Products GmbH 79
Large-scale testing (Phase 3)Active Not RecruitingNCT05860881
What this trial is testing

Topical Sirolimus in Chemoprevention of Facial Squamous Cell Carcinomas in Solid Organ Transplant Recipients (SiroSkin)

Who this might be right for
Solid Organ Transplant RecipientsSkin Cancer
Melanoma and Skin Cancer Trials Limited 146
Not applicableEnded earlyNCT01096381
What this trial is testing

Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor

Who this might be right for
Breast CancerCardiovascular ComplicationsColorectal Cancer+6 more
Vanderbilt-Ingram Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT06036836
What this trial is testing

Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010)

Who this might be right for
Solid TumorCutaneous Squamous Cell CarcinomaEndometrial Cancer
Merck Sharp & Dohme LLC 163
Testing effectiveness (Phase 2)UnknownNCT05329792
What this trial is testing

L19IL2/L19TNF in Skin Cancer Patients

Who this might be right for
BCC - Basal Cell CarcinomaSCC - Squamous Cell CarcinomaMerkel Cell Carcinoma+4 more
Philogen S.p.A. 70
Next Page